We Update you with the Clock Running. Health Care News, Disease, Diagnose, Physicians, Residents, Medical Officers, Nursing Care, Technical Staff, Health Policies, Organizations, Certification, Standards, Alerts, and All about Worlds Health. Step to Facilitate the Health Care Professionals and Patients. Provide Safety and Quality to Patient's, Health Care staff, Explains Patient Family Education and Rights.
Publication Of Clinical Results Underscores VELCADE(R) (Bortezomib) For Injection Based Therapy As A Standard Of Care In Multiple Myeloma Patients
Blood / Hematology Millennium Pharmaceuticals, Inc. (Nasdaq: MLNM) announced the publication of updated results of the Phase I/II clinical trial of the combination therapy VELCADE, melphalan and prednisone (VcMP) in newly diagnosed multiple myeloma patients, who were ineligible for stem cell transplantation.
Custom Search
